Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Estrogens”

1,252 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,252 results

Early research (Phase 1)Ended earlyNCT03816839
What this trial is testing

Evaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced Breast Cancer (AMEERA-2)

Who this might be right for
Breast Cancer
Sanofi 10
Large-scale testing (Phase 3)Study completedNCT01626222
What this trial is testing

4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Novartis Pharmaceuticals 301
Not applicableUnknownNCT03329898
What this trial is testing

Comparing the Efficacy of Two Methods for the Therapy of Uterine Adhesion

Who this might be right for
Intrauterine Adhesion
Beijing Obstetrics and Gynecology Hospital 200
Testing effectiveness (Phase 2)Study completedNCT00000612
What this trial is testing

Soy Estrogen Alternative Study (SEA)

Who this might be right for
Cardiovascular DiseasesEndometrial HyperplasiaHeart Diseases+3 more
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableStudy completedNCT00068328
What this trial is testing

Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer

Who this might be right for
Breast CancerPsychosocial Effects of Cancer and Its Treatment
Alliance for Clinical Trials in Oncology 1,706
Early research (Phase 1)Study completedNCT00864214
What this trial is testing

A Pharmacokinetic Evaluation of Bioidentical Compounded Estrogen Cream and Natural Progesterone

Who this might be right for
Menopause
Mayo Clinic 40
Large-scale testing (Phase 3)Study completedNCT00464971
What this trial is testing

Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Atrophic Vaginitis: An Extension Trial

Who this might be right for
MenopausePostmenopausal Vaginal Atrophy
Novo Nordisk A/S 102
Testing effectiveness (Phase 2)Study completedNCT03870399
What this trial is testing

Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression

Who this might be right for
Neuroendocrine TumorsProgesterone Receptor Positive TumorEstrogen Receptor Positive Tumor
AC Camargo Cancer Center 23
Large-scale testing (Phase 3)Ended earlyNCT00097344
What this trial is testing

The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasms, Hormone-Dependent
Intarcia Therapeutics 842
Testing effectiveness (Phase 2)Study completedNCT00997893
What this trial is testing

Research Investigation of Soy and Estrogen

Who this might be right for
MenopauseHot Flashes
University of Illinois at Chicago 96
Post-approval studies (Phase 4)Study completedNCT02255175
What this trial is testing

Perimenopausal Effects of Estradiol on Reward Responsiveness

Who this might be right for
Perimenopausal Depression
University of North Carolina, Chapel Hill 64
Testing effectiveness (Phase 2)Study completedNCT00000421
What this trial is testing

Serologically Active, Clinically Stable Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
NYU Langone Health 154
Testing effectiveness (Phase 2)UnknownNCT01466114
What this trial is testing

Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition

Who this might be right for
Relapsing-remitting Multiple SclerosisSecondary-progressive Multiple SclerosisPrimary-progressive Multiple Sclerosis
University of California, Los Angeles 64
Not applicableStudy completedNCT03786393
What this trial is testing

Estrogen Receptor 1 Gene Polymorphism Frequency in Fibromyalgia Syndrome

Who this might be right for
Fibromyalgia
Nigde Omer Halisdemir University 200
Not applicableStudy completedNCT03505736
What this trial is testing

Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+18 more
Wake Forest University Health Sciences 25
Testing effectiveness (Phase 2)UnknownNCT04997798
What this trial is testing

Dalpiciclib in Combination With Exemestane and Trastuzumab Plus Pyrotinib in Early Triple Positive Breast Cancer

Who this might be right for
Breast CancerEstrogen Receptor Positive TumorHER2-positive Breast Cancer
First Affiliated Hospital of Zhejiang University 30
Large-scale testing (Phase 3)Looking for participantsNCT02535221
What this trial is testing

Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer

Who this might be right for
Breast Cancer
Peking University 234
Testing effectiveness (Phase 2)Study completedNCT02049957
What this trial is testing

Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Calithera Biosciences, Inc 118
Not applicableStudy completedNCT00340665
What this trial is testing

Study of Infant Diets on Estrogen Activity and Development

Who this might be right for
Infant FormulaEstrogen Activity
National Institute of Environmental Health Sciences (NIEHS) 239
Early research (Phase 1)Study completedNCT01145430
What this trial is testing

Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor NegativeHER2/Neu NegativeMale Breast Carcinoma+7 more
National Cancer Institute (NCI) 45
Load More Results